Dianthus Therapeutics | MGTA - Umlaufvermögen

Aktienkurs
87.39
Täglich Wechseln
-2.43 -2.71%
Monatlich
9.77%
Jährlich
303.28%
Q2 Prognose
85.52




Umlaufvermögen Veränderung Datum
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alaunos Therapeutics USD 2.68M 1.05M 2025-09
Avita Medical AUD 35.49M 760K 2025-12
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 409.44M 4.39M 2025-12
Divis Laboratories Ltd INR 98.43B 2.38B 2025-09
IQVIA Holdings USD 6.25B 270M 2025-12
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 6.54B 54M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Organon & Co USD 4.7B 82M 2025-09
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pharma Mar EUR 283.41M 40.53M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Revvity USD 2.24B 95.96M 2025-12
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 9.79B 162.2M 2025-12
Xeris Pharmaceuticals USD 240.31M 16.3M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 10.7B 1.59B 2025-09